TNF: a moonlighting protein at the interface between cancer and infection

No Thumbnail Available
Files
There are no files associated with this item.
Date
2008
Authors
Hundsberger, Harald
Verin, Alexander
Wiesner, Christoph
Pflüger, Maren
Dulebo, Alexander
Schütt, Wolfgang
Lasters, Ignace
Männel, Daniela N.
Lucas, Rudolf
Editors
Contact
Journal ISSN
Electronic ISSN
ISBN
Bibliographical data
Publisher
Series
DOI (citable link)
ArXiv-ID
International patent number
Link to the license
EU project number
Project
Open Access publication
Collections
Restricted until
Title in another language
Research Projects
Organizational Units
Journal Issue
Publication type
Journal article
Publication status
Published in
Frontiers in Bioscience ; 13 (2008), 14. - pp. 5374-5386. - ISSN 1093-9946. - eISSN 1093-4715
Abstract
The remarkable ability of TNF, especially in combination with Interferon-gamma or melphalan, to inhibit the growth of malignant tumor cells is so far unmatched. Unfortunately, its high systemic toxicity and hepatotoxicity prevent its systemic use in cancer patients. An elegant manner to circumvent this problem is the isolated limb and liver perfusion for the treatment of melanoma, soft tissue sarcoma and liver tumors, respectively, although the latter method can lead to a reversible hepatotoxicity. In order to allow also the treatment of other cancers with TNF, new strategies have to be developed that aim at sensitizing tumor cells to TNF and at reducing its systemic and liver toxicity, without losing its antitumor efficiency. Moreover, the lectin-like domain of TNF, which is spatially distinct from the receptor binding sites, could be useful in reducing cancer treatment-related pulmonary edema formation. This review will discuss some recent developments in these areas, which can lead to a renewed interest in TNF for the systemic treatment of cancer.
Summary in another language
Subject (DDC)
570 Biosciences, Biology
Keywords
Conference
Review
undefined / . - undefined, undefined. - (undefined; undefined)
Cite This
ISO 690HUNDSBERGER, Harald, Alexander VERIN, Christoph WIESNER, Maren PFLÜGER, Alexander DULEBO, Wolfgang SCHÜTT, Ignace LASTERS, Daniela N. MÄNNEL, Albrecht WENDEL, Rudolf LUCAS, 2008. TNF: a moonlighting protein at the interface between cancer and infection. In: Frontiers in Bioscience. 13(14), pp. 5374-5386. ISSN 1093-9946. eISSN 1093-4715. Available under: doi: 10.2741/3087
BibTex
@article{Hundsberger2008moonl-1244,
  year={2008},
  doi={10.2741/3087},
  title={TNF: a moonlighting protein at the interface between cancer and infection},
  number={14},
  volume={13},
  issn={1093-9946},
  journal={Frontiers in Bioscience},
  pages={5374--5386},
  author={Hundsberger, Harald and Verin, Alexander and Wiesner, Christoph and Pflüger, Maren and Dulebo, Alexander and Schütt, Wolfgang and Lasters, Ignace and Männel, Daniela N. and Wendel, Albrecht and Lucas, Rudolf}
}
RDF
<rdf:RDF
    xmlns:dcterms="http://purl.org/dc/terms/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
    xmlns:bibo="http://purl.org/ontology/bibo/"
    xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#"
    xmlns:foaf="http://xmlns.com/foaf/0.1/"
    xmlns:void="http://rdfs.org/ns/void#"
    xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > 
  <rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/1244">
    <dc:creator>Hundsberger, Harald</dc:creator>
    <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/>
    <dc:contributor>Lucas, Rudolf</dc:contributor>
    <dc:creator>Männel, Daniela N.</dc:creator>
    <dcterms:issued>2008</dcterms:issued>
    <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
    <dc:contributor>Männel, Daniela N.</dc:contributor>
    <dc:creator>Dulebo, Alexander</dc:creator>
    <dcterms:title>TNF: a moonlighting protein at the interface between cancer and infection</dcterms:title>
    <dc:contributor>Lasters, Ignace</dc:contributor>
    <dcterms:rights rdf:resource="https://rightsstatements.org/page/InC/1.0/"/>
    <dc:contributor>Wendel, Albrecht</dc:contributor>
    <dc:contributor>Hundsberger, Harald</dc:contributor>
    <dc:contributor>Pflüger, Maren</dc:contributor>
    <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2011-03-23T09:07:23Z</dcterms:available>
    <dc:creator>Wiesner, Christoph</dc:creator>
    <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2011-03-23T09:07:23Z</dc:date>
    <dc:contributor>Dulebo, Alexander</dc:contributor>
    <dc:creator>Schütt, Wolfgang</dc:creator>
    <dc:creator>Pflüger, Maren</dc:creator>
    <dc:creator>Lasters, Ignace</dc:creator>
    <dc:contributor>Schütt, Wolfgang</dc:contributor>
    <dc:creator>Lucas, Rudolf</dc:creator>
    <dcterms:abstract xml:lang="eng">The remarkable ability of TNF, especially in combination with Interferon-gamma or melphalan, to inhibit the growth of malignant tumor cells is so far unmatched. Unfortunately, its high systemic toxicity and hepatotoxicity prevent its systemic use in cancer patients. An elegant manner to circumvent this problem is the isolated limb and liver perfusion for the treatment of melanoma, soft tissue sarcoma and liver tumors, respectively, although the latter method can lead to a reversible hepatotoxicity. In order to allow also the treatment of other cancers with TNF, new strategies have to be developed that aim at sensitizing tumor cells to TNF and at reducing its systemic and liver toxicity, without losing its antitumor efficiency. Moreover, the lectin-like domain of TNF, which is spatially distinct from the receptor binding sites, could be useful in reducing cancer treatment-related pulmonary edema formation. This review will discuss some recent developments in these areas, which can lead to a renewed interest in TNF for the systemic treatment of cancer.</dcterms:abstract>
    <bibo:uri rdf:resource="http://kops.uni-konstanz.de/handle/123456789/1244"/>
    <foaf:homepage rdf:resource="http://localhost:8080/"/>
    <dcterms:bibliographicCitation>Publ. in: Frontiers in Bioscience 13 (2008), 14, pp. 5374-5386</dcterms:bibliographicCitation>
    <dc:creator>Verin, Alexander</dc:creator>
    <dc:language>eng</dc:language>
    <dc:contributor>Wiesner, Christoph</dc:contributor>
    <dc:creator>Wendel, Albrecht</dc:creator>
    <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
    <dc:contributor>Verin, Alexander</dc:contributor>
    <dc:rights>terms-of-use</dc:rights>
  </rdf:Description>
</rdf:RDF>
Internal note
xmlui.Submission.submit.DescribeStep.inputForms.label.kops_note_fromSubmitter
Contact
URL of original publication
Test date of URL
Examination date of dissertation
Method of financing
Comment on publication
Alliance license
Corresponding Authors der Uni Konstanz vorhanden
International Co-Authors
Bibliography of Konstanz
Yes
Refereed